Literature DB >> 22085928

Regulation of p53 stability and function by the deubiquitinating enzyme USP42.

Andreas K Hock1, Arnaud M Vigneron, Stephanie Carter, Robert L Ludwig, Karen H Vousden.   

Abstract

The p53 tumour suppressor protein is a transcription factor that prevents oncogenic progression by activating the expression of apoptosis and cell-cycle arrest genes in stressed cells. The stability of p53 is tightly regulated by ubiquitin-dependent degradation, driven mainly by the ubiquitin ligase MDM2. In this study, we have identified USP42 as a DUB that interacts with and deubiquitinates p53. USP42 forms a direct complex with p53 and controls level of ubiquitination during the early phase of the response to a range of stress signals. Although we do not find a clear role for USP42 in controlling either the basal or fully activated levels of p53, the function of USP42 is required to allow the rapid activation of p53-dependent transcription and a p53-dependent cell-cycle arrest in response to stress. These functions of USP42 are likely to contribute to the repair and recovery of cells from mild or transient damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085928      PMCID: PMC3243628          DOI: 10.1038/emboj.2011.419

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  32 in total

1.  Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.

Authors:  S Fang; J P Jensen; R L Ludwig; K H Vousden; A M Weissman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 2.  p53 and human cancer: the first ten thousand mutations.

Authors:  P Hainaut; M Hollstein
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

3.  Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.

Authors:  Muyang Li; Delin Chen; Ariel Shiloh; Jianyuan Luo; Anatoly Y Nikolaev; Jun Qin; Wei Gu
Journal:  Nature       Date:  2002-03-31       Impact factor: 49.962

Review 4.  Single-nucleotide polymorphisms in the p53 signaling pathway.

Authors:  Lukasz F Grochola; Jorge Zeron-Medina; Sophie Mériaux; Gareth L Bond
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

5.  JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress.

Authors:  Juhong Liu; Hye-Jung Chung; Matthew Vogt; Yetao Jin; Daniela Malide; Liusheng He; Miroslav Dundr; David Levens
Journal:  EMBO J       Date:  2011-02-01       Impact factor: 11.598

6.  Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.

Authors:  Arnaud M Vigneron; Robert L Ludwig; Karen H Vousden
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

7.  Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53.

Authors:  Saurabh Dayal; Alison Sparks; Jimmy Jacob; Nerea Allende-Vega; David P Lane; Mark K Saville
Journal:  J Biol Chem       Date:  2008-12-19       Impact factor: 5.157

8.  USP10 regulates p53 localization and stability by deubiquitinating p53.

Authors:  Jian Yuan; Kuntian Luo; Lizhi Zhang; John C Cheville; Zhenkun Lou
Journal:  Cell       Date:  2010-01-21       Impact factor: 41.582

Review 9.  TP53 status and response to chemotherapy in breast cancer.

Authors:  Philippe Bertheau; Marc Espié; Elisabeth Turpin; Jacqueline Lehmann; Louis-François Plassa; Mariana Varna; Anne Janin; Hugues de Thé
Journal:  Pathobiology       Date:  2008-06-10       Impact factor: 4.342

Review 10.  The mitochondrial p53 pathway.

Authors:  Angelina V Vaseva; Ute M Moll
Journal:  Biochim Biophys Acta       Date:  2008-10-25
View more
  47 in total

Review 1.  Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.

Authors:  Key-Hwan Lim; Myoung-Hyun Song; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2016-01-13       Impact factor: 9.261

2.  Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein.

Authors:  Yuhuang Li; Xiao-Xin Sun; Johannes Elferich; Ujwal Shinde; Larry L David; Mu-Shui Dai
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

3.  Decoding ubiquitin for mitosis.

Authors:  Sadek Fournane; Ksenia Krupina; Charlotte Kleiss; Izabela Sumara
Journal:  Genes Cancer       Date:  2012-11

Review 4.  Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1.

Authors:  Xiao-Xin Sun; Mu-Shui Dai
Journal:  World J Biol Chem       Date:  2014-05-26

Review 5.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

6.  Dissenting degradation: Deubiquitinases in cell cycle and cancer.

Authors:  Thomas Bonacci; Michael J Emanuele
Journal:  Semin Cancer Biol       Date:  2020-03-20       Impact factor: 15.707

Review 7.  The Ubiquitin Proteasome System and Skin Fibrosis.

Authors:  Wanlu Shen; Zhigang Zhang; Jiaqing Ma; Di Lu; Lechun Lyu
Journal:  Mol Diagn Ther       Date:  2021-01-12       Impact factor: 4.074

Review 8.  The WD40-repeat protein-containing deubiquitinase complex: catalysis, regulation, and potential for therapeutic intervention.

Authors:  Mark A Villamil; Qin Liang; Zhihao Zhuang
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

9.  The transcription factor Cux1 in cerebellar granule cell development and medulloblastoma pathogenesis.

Authors:  Sabine Topka; Alexander Glassmann; Gunnar Weisheit; Ulrich Schüller; Karl Schilling
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

Review 10.  Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

Authors:  Tiffany Devine; Mu-Shui Dai
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.